These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37276599)

  • 141. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Priority pharmacogenetics for the African continent: focus on CYP450.
    Alessandrini M; Pepper MS
    Pharmacogenomics; 2014 Feb; 15(3):385-400. PubMed ID: 24533717
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Role of dermatology in pharmacogenomics: drug-induced skin injury.
    Borroni RG
    Pharmacogenomics; 2015; 16(4):401-12. PubMed ID: 25823788
    [TBL] [Abstract][Full Text] [Related]  

  • 144. HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
    Negrini S; Becquemont L
    Pharmacogenomics; 2017 Oct; 18(15):1441-1457. PubMed ID: 29017379
    [TBL] [Abstract][Full Text] [Related]  

  • 145. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 146. The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions.
    Pirmohamed M; Aithal GP; Behr E; Daly A; Roden D
    Clin Pharmacol Ther; 2011 Jun; 89(6):784-5. PubMed ID: 21593754
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Pharmacogenetics in clinical dermatology.
    Ameen M; Smith CH; Barker JN
    Br J Dermatol; 2002 Jan; 146(1):2-6. PubMed ID: 11841360
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Pharmacogenetic Markers of Drug Efficacy and Toxicity.
    Yip VL; Hawcutt DB; Pirmohamed M
    Clin Pharmacol Ther; 2015 Jul; 98(1):61-70. PubMed ID: 25870137
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions.
    Pirmohamed M
    Annu Rev Genomics Hum Genet; 2014; 15():349-70. PubMed ID: 24898040
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Implementation of inpatient models of pharmacogenetics programs.
    Cavallari LH; Lee CR; Duarte JD; Nutescu EA; Weitzel KW; Stouffer GA; Johnson JA
    Am J Health Syst Pharm; 2016 Dec; 73(23):1944-1954. PubMed ID: 27864202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 8.